BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6300304)

  • 21. Some particularities of Sendai virus multiplication in chorioallantoic membrane fragments.
    Samuel I; Tomas E
    Virologie; 1980; 31(2):111-6. PubMed ID: 6250276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection of mice by a protease inhibitor, aprotinin, against lethal Sendai virus pneumonia.
    Hayashi T; Hotta H; Itoh M; Homma M
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():979-82. PubMed ID: 1707950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity.
    Tashiro M; Yokogoshi Y; Tobita K; Seto JT; Rott R; Kido H
    J Virol; 1992 Dec; 66(12):7211-6. PubMed ID: 1331518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of trypsin on the infectivity and biological properties or parainfluenza type 2 type 2 (croup-associated) virus in Vero cells.
    Shimokata K; Ito Y; Nishiyama Y; Kimura Y
    J Gen Virol; 1980 Jun; 48(Pt 2):407-10. PubMed ID: 6249888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary surfactant is a potential endogenous inhibitor of proteolytic activation of Sendai virus and influenza A virus.
    Kido H; Sakai K; Kishino Y; Tashiro M
    FEBS Lett; 1993 May; 322(2):115-9. PubMed ID: 8387030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of Sendai virus with human erythrocytes. IV - Hemolytic factors.
    CaliĆ² R; CaliĆ² Villani N; Firriolo A
    Boll Ist Sieroter Milan; 1978 Sep; 57(4):393-7. PubMed ID: 216375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myxovirus replication in chicken embryos can be suppressed by aprotinin due to the blockage of viral glycoprotein cleavage.
    Zhirnov OP; Ovcharenko AV; Bukrinskaya AG
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1633-8. PubMed ID: 2410557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of polysome formation and protein synthesis in Sendai virus-infected cells.
    Zaides VM; Selimova LM; Nicolaeva OG; Bukrinskaya AG
    J Gen Virol; 1976 May; 31(2):193-7. PubMed ID: 180240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteolytic activation of influenza WSN virus in cultured cells is performed by homologous plasma enzymes.
    Zhirnov OP; Ovcharenko AV; Bukrinskaya AG
    J Gen Virol; 1982 Dec; 63(2):469-74. PubMed ID: 6218257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of interferon on the replication of Sendai virus.
    Richman DD; Wong KT; Robinson WS; Merigan TC
    J Gen Virol; 1970 Nov; 9(2):141-50. PubMed ID: 4320690
    [No Abstract]   [Full Text] [Related]  

  • 31. Development of protease activation mutants of HVJ (Sendai virus) in persistently infected cell cultures.
    Ogura H; Sato H; Sato Y; Hatano M
    J Gen Virol; 1982 Aug; 61 (Pt 2)():207-15. PubMed ID: 6288855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein synthesis in Sendai virus-infected cells.
    Zaides VM; Selimova LM; Zhirnov OP; Bukrinskaya AG
    J Gen Virol; 1975 Jun; 27(3):319-27. PubMed ID: 167115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational changes of the protease susceptibility of glycoprotein F of Newcastle disease virus: effects on pathogenicity.
    Garten W; Berk W; Nagai Y; Rott R; Klenk HD
    J Gen Virol; 1980 Sep; 50(1):135-47. PubMed ID: 7441209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biological properties of plaque-size variants of Sendai virus.
    Sugita K; Maru M; Sato K
    Microbiol Immunol; 1981; 25(4):353-60. PubMed ID: 6265739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of proteolytic enzymes on the infectivity of vaccinia virus.
    Ichihashi Y; Tsuruhara T; Oie M
    Virology; 1982 Oct; 122(2):279-89. PubMed ID: 6183818
    [No Abstract]   [Full Text] [Related]  

  • 36. Specific alteration of Sendai virus glycoprotein subunits.
    Popa LM; Repanovici R
    Acta Virol; 1979 Jan; 23(1):21-31. PubMed ID: 35955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of mice from wild-type Sendai virus infection by a trypsin-resistant mutant, TR-2.
    Tashiro M; Homma M
    J Virol; 1985 Jan; 53(1):228-34. PubMed ID: 2981341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transient rescue of Sendai-6/94 cl virus from the persistently infected cell line Cl-E-8 by cocultivation.
    Neubert WJ; Hofschneider PH
    Virology; 1983 Mar; 125(2):445-53. PubMed ID: 6301147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutathione inhibits replication and expression of viral proteins in cultured cells infected with Sendai virus.
    Garaci E; Palamara AT; Di Francesco P; Favalli C; Ciriolo MR; Rotilio G
    Biochem Biophys Res Commun; 1992 Nov; 188(3):1090-6. PubMed ID: 1332709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A protease activation mutant, MVCES1, as a safe and potent live vaccine derived from currently prevailing Sendai virus.
    Wang XL; Itoh M; Hotta H; Homma M
    J Virol; 1994 May; 68(5):3369-73. PubMed ID: 8151795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.